(Q51804140)

12 April 2018

title

Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study. (English)

1 reference

12 April 2018

1 reference

7

Patrick Pessaux

1 reference

12 April 2018

author name string

Mahfud Mahfud

1

1 reference

12 April 2018

Stefan Breitenstein

2

1 reference

12 April 2018

Ashraf Mohammad El-Badry

3

1 reference

12 April 2018

Milo Puhan

4

1 reference

12 April 2018

Andreas Rickenbacher

5

1 reference

12 April 2018

Panagiotis Samaras

6

1 reference

12 April 2018

Santiago Lopez-Ben

8

1 reference

12 April 2018

Daniel Jaeck

9

1 reference

12 April 2018

Joan Figueras

10

1 reference

12 April 2018

Pierre Alain-Clavien

11

1 reference

12 April 2018

publication date

1 January 2010

1 reference

12 April 2018

number of pages

9

1 reference

inferred from page(s)

published in

World Journal of Surgery

1 reference

12 April 2018

volume

34

1 reference

12 April 2018

issue

1

1 reference

12 April 2018

page(s)

92-100

1 reference

12 April 2018

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00268-009-0251-8

Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00268-009-0251-8

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

21 January 2018

1 reference

12 December 2020

Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer.

1 reference

12 December 2020

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy

1 reference

12 December 2020

Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab

1 reference

12 December 2020

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

1 reference

12 December 2020

Strategies for safer liver surgery and partial liver transplantation

1 reference

12 December 2020

CASH (Chemotherapy-Associated Steatohepatitis) costs

1 reference

12 December 2020

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

1 reference

12 December 2020

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases

1 reference

12 December 2020

OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

1 reference

12 December 2020

Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases

1 reference

12 December 2020

[Contribution of anatomical research to liver surgery]

1 reference

12 December 2020

Effect of vascular endothelial growth factor on functional recovery after hepatectomy in lean and obese mice

1 reference

12 December 2020

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

1 reference

12 December 2020

Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases

1 reference

12 December 2020

Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases

1 reference

12 December 2020

The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy

1 reference

12 December 2020

Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial

1 reference

12 December 2020

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

1 reference

12 December 2020

Bevacizumab: antiangiogenic cancer therapy

1 reference

12 December 2020

Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release

1 reference

12 December 2020

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

1 reference

12 December 2020

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

1 reference

12 December 2020

Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition

1 reference

12 December 2020

Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.

1 reference

12 December 2020

Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy

1 reference

12 December 2020

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

1 reference

12 December 2020

Antiangiogenic drugs currently used for colorectal cancer: what other pathways can we target to prolong responses?

1 reference

12 December 2020

Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases

1 reference

12 December 2020

Lack of Evidence for Increased Operative Morbidity After Hepatectomy with Perioperative Use of Bevacizumab: A Matched Case-Control Study

1 reference

12 December 2020

Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines

1 reference

12 December 2020

Mechanisms of action of bevacizumab as a component of therapy for metastatic colorectal cancer

1 reference

12 December 2020

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

1 reference

12 December 2020

Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy

1 reference

12 December 2020

Terminology of liver anatomy and liver resections: coming to grips with hepatic Babel.

1 reference

12 December 2020

Platelets Take Up the Monoclonal Antibody Bevacizumab

1 reference

12 December 2020

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

1 reference

12 December 2020

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival

1 reference

12 December 2020

Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal

1 reference

12 December 2020

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases

1 reference

12 December 2020

Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer

1 reference

12 December 2020

10.1007/S00268-009-0251-8

Identifiers

DOI

1 reference

12 April 2018

1 reference

12 April 2018